REVE TECHNOLOGIES, INC.

CIK:0001495028|SEC Filings

Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
Statements of Operations (Unaudited) - USD ($)	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Revenues:
Revenue	$ 0	$ 0	$ 0	$ 0
Operating expense:
Selling, general and administrative	3,767	7,551	39,170	17,593
Product development	0	11,025	167,766	32,432
Executive compensation	7,823	15,000	70,701	43,639
Professional fees	18,181	11,456	63,906	30,427
Total operating expense	29,771	45,032	341,543	124,091
Loss from operations	(29,771)	(45,032)	(341,543)	(124,091)
Other expense:
Interest expense	(85,133)	(151)	(169,064)	(416)
Interest expense - related party	(5,642)	(19,564)	(66,471)	(60,543)
Change in derivative liability	60,577	0	(134,310)	(51,515)
Total other expense	(30,198)	(19,715)	(369,845)	(112,474)
Net loss	$ (59,969)	$ (64,747)	$ (711,388)	$ (236,565)
Loss per Common Share	$ 0.00	$ 0.00	$ (0.02)	$ (0.01)
Weighted average number of common shares outstanding - basic	49,013,226	36,997,970	41,068,995	36,997,970

Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
Statements of Cash Flows (Unaudited) - USD ($)	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities
Net loss	$ (711,388)	$ (236,565)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation	606	297
Accretion of debt discount	211,243	49,569
Legal fees paid in connection with convertible notes	6,750	0
Change in derivative liability	134,310	51,515
Changes in operating assets and liabilities:
Decrease (increase) in prepaid expenses	6,300	1,225
Increase (decrease) in accounts payable	174,208	(3,019)
Increase (decrease) in interest payable	7,420	422
Increase (decrease) in interest payable - related party	16,873	10,973
Net cash used in operating activities	(153,678)	(125,582)
Cash flows from investing activity
Proceeds for notes receivable - related party	0	(1,955)
Payments for notes receivable - related party	0	5
Net cash used in investing activity	0	(1,950)
Cash flows from financing activities
Proceeds from share subscription	26,000	0
Payment on shares purchase backe	(25,000)	0
Proceeds from convertible notes payable	104,750	130,895
Repayment of convertible notes payable	0	(1,870)
Net cash provided by financing activities	114,750	129,025
Increase (decrease) in cash and cash equivalents	(38,928)	1,493
Cash and cash equivalents at beginning of period	48,928	120
Cash and cash equivalents at end of period	1,000	1,613
Supplemental disclosure of cash flow information:
Interest paid in cash	0	0
Income taxes paid in cash	0	0
Supplemental disclosure of non-cash transactions:
Convertible note issued due to settle note payable and interest payable to related party	29,800	0
Debt discount recorded for beneficial conversion feature	0	44,880
Debt discount recorded for beneficial conversion feature	$ 0	$ 34,717

Balance Sheets - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Current assets:
Cash and cash equivalents	$ 1,000	$ 48,928
Prepaid expenses	0	6,300
Total current assets	0	55,228
Other receivable	8,691	0
Equipment, net of accumulated depreciation of $759 and $558, respectively	1,261	1,866
TOTAL ASSETS	10,952	57,094
Current liabilities:
Accounts payable	198,035	8,739
Line of credit	11,160	10,713
Convertible notes - related party, net of discount of $0 and $49,598	258,083	233,484
Interest payable - related party	33,682	21,609
Convertible notes - net of discount of $15,345 and $52,829	82,080	4,921
Derivative liability	116,141	91,526
Total current liabilities	699,181	370,992
Long-term Liabilities:
Convertible notes - net of discount of $53,382 and $26,714	26,231	1,064
Derivative liability	147,592	92,643
Total long-term liabilities	173,883	93,707
TOTAL LIABILITIES	$ 873,004	$ 464,699
Commitments and contingencies
Stockholders' deficit:
Preferred stock: $0.001 par value; 10,000,000 shares authorized, no shares issued and outstanding	$ 0	$ 0
Common stock: $0.001 par value; 1,000,000,000 shares authorized, 57,439,461 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively	57,440	36,998
Additional paid-in capital	595,297	358,798
Accumulated deficit	(1,514,789)	(803,401)
Total stockholders' deficit	(862,052)	(407,605)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 9,952	$ 57,094